The liver pharmacological and xenobiotic gene response repertoire

Molecular Systems Biology

Volumn 4, Issue , 2008, Pages 175-

  Natsoulis, Georges ^a,b   Pearson, Cecelia I ^a   Gollub, Jeremy ^a   P Eynon, Barrett ^a   Ferng, Joe ^a   Nair, Ramesh ^a   Idury, Radha ^a   Lee, May D ^a,c   Fielden, Mark R ^a,d   Brennan, Richard J ^a,e   Roter, Alan H ^a   Jarnagin, Kurt ^a  

^a Entelos Inc   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Limerick NeuroSciences   (United States)

^d ROCHE BIOSCIENCE   (United States)

^e GeneGo bioinformatics software Inc   (United States)

Author keywords

Biomarker; Data mining; Liver; Toxicity; Toxicology; Xenobiotic

Indexed keywords

XENOBIOTIC AGENT;

ARTICLE; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC DATABASE; IMMUNE RESPONSE; LIVER FIBROSIS; MICROARRAY ANALYSIS; NONHUMAN; PHARMACOLOGICAL SCIENCE; PHENOTYPE; PRIORITY JOURNAL; SIMULATION; XENOBIOTIC METABOLISM;

ANIMALS; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; LIVER; LIVER CIRRHOSIS; RATS; REPRODUCIBILITY OF RESULTS; XENOBIOTICS;

RATTUS;

EID: 41149111051     PISSN: 17444292     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb.2008.9     Document Type: Article

References (36)

1. Alcolado R, Arthur MJ, Iredale JP (1997) Pathogenesis of liver fibrosis. Clin Sci (Lond) 92: 103-112
2. Allison DB, Cui X, Page GP, Sabripour M (2006) Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 7: 55-65
3. El Ghaoui L, Lanckriet GRG, Natsoulis G (2003) Robust classifiers with interval data. Report no. UCB/CSD-03-1279 Computer Science Division (EECS), University of California, Berkeley, CA
4. Elrick M, Kramer J, Alden C, Blomme E, Bunch R, Cabonce M, Curtiss S, Kier L, Kolaja K, Rodi C (2005) Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity. Toxicol Pathol 33: 118-126
5. Eng FJ, Friedman SL (2000) Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol Gastrointest Liver Physiol 279: G7-G11
6. Gabele E, Brenner DA, Rippe RA (2003) Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 8: d69-d77
7. Ganter B, Tugendreich S, Pearson CI, Ayanoglu E, Baumhueter S, Bostian KA, Brady L, Browne LJ, Calvin JT, Day GJ, Breckenridge N, Dunlea S, Eynon BP, Furness LM, Ferng J, Fielden MR, Fujimoto SY, Gong L, Hu C, Idury R et al (2005) Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol 119: 219-244
8. Gnainsky Y, Kushnirsky Z, Bilu G, Hagai Y, Genina O, Volpin H, Bruck R, Spira G, Nagler A, Kawada N, Yoshizato K, Reinhardt DP, Libermann TA, Pines M (2007) Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling. Cell Tissue Res 328: 153-166
9. Hamadeh H, Bushel P, Jayadev S, Martin K, DiSorbo O, Sieber S, Bennett L, Tennant R, Stoll R, Barrett J (2002) Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 67: 219
10. Hastie T, Tibshirani R, Eisen MB, Alizadeh A, Levy R, Staudt L, Chan WC, Botstein D, Brown P (2000) 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol 1: RESEARCH0003
11. Hastie T, Tibshirani R, Friedman J (2001) Elements of Statistical Learning: Data Mining, Inference and Prediction. New York, USA: Springer-Verlag
12. Heinloth A, Irwin R, Boorman G, Nettesheim P, Fannin R, Sieber S, Snell M, Tucker C, Li L, Travlos G (2004) Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol Sci 80: 193
13. Huang Q, Jin X, Gaillard ET, Knight BL, Pack FD, Stoltz JH, Jayadev S, Blanchard KT (2004) Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants. Mutat Res 549: 147-167
14. Ioannides C (2002) Enzyme Systems that Metabolise Drugs and Other Xenobiotics. Chichester, New York, USA: John Wiley & Sons
15. Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117: 539-548
16. Jiang Y, Liu J, Waalkes M, Kang YJ (2004) Changes in the gene expression associated with carbon tetrachloride-induced liver fibrosis persist after cessation of dosing in mice. Toxicol Sci 79: 404-410
17. Kim BS, Margolin BH (1999) Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests. Environ Mol Mutagen 34: 297-304
18. Lamb J, Crawford E, Peck D, Modell J, Blat I, Wrobel M, Lerner J, Brunet J, Subramanian A, Ross K (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929
19. Leveille CR, Arias IM (1993) Pathophysiology and pharmacologic modulation of hepatic fibrosis. J Vet Intern Med 7: 73-84
20. Liu Y, Ringner M (2004) Multiclass discovery in array data. BMC Bioinformatics 5: 70
21. Loy CT, Irwig L, Mistry K, Cable G, Kim BS, Margolin BH (2004) Accuracy of diagnostic tests read with and without clinical information: a systematic review. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests. JAMA 292: 1602-1609
22. Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR, Bradley A (1995) Multiple defects and perinatal death in mice deficient in follistatin. Nature 374: 360-363
23. Michiels S, Koscielny S, Hill C (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365: 488-492
24. Mistry K, Cable G (2003) Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. J Am Board Fam Pract 16: 95-101
25. Natsoulis G, El Ghaoui L, Lanckriet GR, Tolley AM, Leroy F, Dunlea S, Eynon BP, Pearson CI, Tugendreich S, Jarnagin K (2005) Classification of a large microarray data set: algorithm comparison and analysis of drug signatures. Genome Res 15: 724-736
26. Nie A, McMillian M, Brandon Parker J, Leone A, Bryant S, Yieh L, Bittner A, Nelson J, Carmen A, Wan J (2006) Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Mol Carcinog 45: 914-933
27. Peters JM, Cattley RC, Gonzalez FJ (1997) Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18: 2029-2033
28. Quackenbush J (2001) Computational analysis of microarray data. Nat Rev Genet 2: 418-427
29. Ramm GA, Carr SC, Bridle KR, Li L, Britton RS, Crawford DH, Vogler CA, Bacon BR, Tracy TF (2000) Morphology of liver repair following cholestatic liver injury: resolution of ductal hyperplasia, matrix deposition and regression of myofibroblasts. Liver 20: 387-396
30. Simon R, Radmacher MD, Dobbin K, McShane LM (2003) Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 95: 14-18
31. Slatter J, Templeton I, Castle J, Kulkarni A, Rushmore T, Richards K, He Y, Dai X, Cheng O, Caguyong M (2006) Compendium of gene expression profiles comprising a baseline model of the human liver drug metabolism transcriptome. Xenobiotica 36: 938-962
32. Takahara Y, Takahashi M, Wagatsuma H, Yokoya F, Zhang QW, Yamaguchi M, Aburatani H, Kawada N (2006) Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis. World J Gastroenterol 12: 6473-6499
33. Utsunomiya T, Okamoto M, Hashimoto M, Yoshinaga K, Shiraishi T, Tanaka F, Mimori K, Inoue H, Watanabe G, Barnard GF, Mori M (2004) A gene-expression signature can quantify the degree of hepatic fibrosis in the rat. J Hepatol 41: 399-406
34. Varma S, Simon R (2006) Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics 7: 91
35. Waring J, Ulrich R (2000) The impact of genomics-based technologies on drug safety evaluation. Annu Rev Pharmacol Toxicol 40: 335-352
36. Zhu HJ, Burgess AW (2001) Regulation of transforming growth factorbeta signaling. Mol Cell Biol Res Commun 4: 321-330